Fig. 7 | Signal Transduction and Targeted Therapy

Fig. 7

From: Liquid–liquid phase separation in human health and diseases

Fig. 7

Phase separation in neurodegenerative disease. Schematic representation of brain areas containing pathological aggregates of four kinds of neurodegenerative diseases. This figure also summarizes disease-associated mutations and PTMs that decrease (red) or enhance (blue) LLPS compared with unmodified TDP-43, FUS, a-synuclein, or tau, as indicated. NTD: N-terminal domain, RRM: RNA-recognition motif, QGSY-rich: rich in glutamine, glycine, serine, and tyrosine, RGG: arginine/glycine-rich; ZnF, zinc finger; NLS, nuclear localization signal; NAC, non-Ab component of AD plaque; N1–2, polypeptide sequences encoded by exons 2 and 3; PRR, proline-rich regions; R1–4, microtubule-binding domains encoded by exons 9–12; p, phosphorylation; m, methylation; a, acetylation

Back to article page